Virpax Pharmaceuticals In... (VRPX)
0.24
0.01 (5.63%)
At close: Feb 28, 2025, 3:59 PM
0.21
-13.76%
Pre-market: Mar 03, 2025, 05:04 AM EST
No 1D chart data available
| Bid | 0.21 |
| Market Cap | 4.42M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -52.12M |
| EPS (ttm) | -7.24 |
| PE Ratio (ttm) | -0.03 |
| Forward PE | -0.31 |
| Analyst | n/a |
| Ask | 0.21 |
| Volume | 74,257,086 |
| Avg. Volume (20D) | 4,058,836 |
| Open | 0.26 |
| Previous Close | 0.23 |
| Day's Range | 0.23 - 0.29 |
| 52-Week Range | 0.22 - 5.48 |
| Beta | 0.92 |
About VRPX
Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical nonsteroidal anti-inflammatory drug treatment for chronic osteoarthritis of the knee; Probudur, an inject...
Industry Biotechnology
Sector Healthcare
IPO Date Feb 17, 2021
Employees 7
Stock Exchange NASDAQ
Ticker Symbol VRPX
Website https://www.virpaxpharma.com
3 days ago
+5.63%
Virpax Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
3 days ago
-5.14%
Virpax Pharmaceuticals shares are trading higher after the company announced results in the human study for its Molecular Envelope Technology.
